Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Clinical trial NCT07684235 · RECRUITING
Trial details
- NCT number
- NCT07684235
- Sponsor
- Amgen
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-23
- Primary completion
- 2027-12-26
- Enrollment
- 3200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.